A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats

European Journal of Pharmacology

Volumn 618, Issue 1-3, 2009, Pages 52-57

  Yuan, Ming Jie ^a   Huang, Cong Xin ^a   Tang, Yan Hong ^a   Wang, Xi ^a   Huang, He ^a   Chen, Yong Jun ^a   Wang, Tao ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cardiac neural remodeling; Ghrelin; Inflammation response; Myocardial infarction; Nerve growth factor

Indexed keywords

AUTACOID; ENDOTHELIN 1; GHRELIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROMODULIN; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GENE EXPRESSION; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MALE; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC INNERVATION; WESTERN BLOTTING;

ANIMALS; ENDOTHELIN-1; GENE EXPRESSION REGULATION; GHRELIN; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MYOCARDIAL INFARCTION; NERVE GROWTH FACTOR; NF-KAPPA B; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 68949167649     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.07.015     Document Type: Article

References (43)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
2. Brown M.A., and Jones W.K. NF-kappa B action in sepsis: the innate immune system and the heart. Front. Biosci. 9 (2004) 1201-1217
3. Budas G.R., Jovanovic S., Crawford R.M., and Jovanovic A. Hypoxia-induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal K-ATP channels. Faseb. J. 18 (2004) 1046-1048
4. Cao J.M., Chen L.S., KenKnight B.H., Ohara T., Lee M.H., Tsai J., Lai W.W., Karagueuzian H.S., Wolf P.L., Fishbein M.C., and Chen P.S. Nerve sprouting and sudden cardiac death. Circ. Res. 86 (2000) 816-821
5. Cao J.M., Fishbein M.C., Han J.B., Lai W.W., Lai A.C., Wu T.J., Czer L., Wolf P.L., Denton T.A., Shintaku I.P., Chen P.S., and Chen L.S. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 101 (2000) 1960-1969
6. Carter B.D., Kaltschmidt C., Kaltschmidt B., Offenhauser N., Bohm-Matthaei R., Baeuerle P.A., and Barde Y.A. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 272 (1996) 542-545
7. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard J.W., and Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114 (2004) 57-66
8. Enomoto M., Nagaya N., Uematsu M., Okumura H., Nakagawa E., Ono F., Hosoda H., Oya H., Kojima M., Kanmatsuse K., and Kangawa K. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin. Sci. 105 (2003) 431-435
9. Garcia E.A., and Korbonits M. Ghrelin and cardiovascular health. Curr. Opin. Pharmacol. 6 (2006) 142-147
10. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87 (2002) 2988-2991
11. Gordon J.R., and Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346 (1990) 274-276
12. Grabellus F., Levkau B., Sokoll A., Welp H., Schmid C., Deng M.C., Takeda A., Breithardt G., and Baba H.A. Reversible activation of nuclear factor-kappa B in human end-stage heart failure after left ventricular mechanical support. Cardiovasc. Res. 53 (2002) 124-130
13. Guillen I., Blanes M., Gomez-Lechon M.J., and Castell J.V. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am. J. Physiol. 269 (1995) R229-235
14. Hasan W., Jama A., Donohue T., Wernli G., Onyszchuk G., Al-Hafez B., Bilgen M., and Smith P.G. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res. 1124 (2006) 142-154
15. Helset E., Ytrehus K., Tveita T., Kjaeve J., and Jorgensen L. Endothelin-1 causes accumulation of leukocytes in the pulmonary circulation. Circ. Shock. 44 (1994) 201-209
16. Ieda M., Fukuda K., Hisaka Y., Kimura K., Kawaguchi H., Fujita J., Shimoda K., Takeshita E., Okano H., Kurihara Y., Kurihara H., Ishida J., Fukamizu A., Federoff H.J., and Ogawa S. Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J. Clin. Invest. 113 (2004) 876-884
17. Isgaard J., Tivesten A., Friberg P., and Bengtsson B.A. The role of the GH/IGF-I axis for cardiac function and structure. Horm. Metab. Res. 31 (1999) 50-54
18. Kawano S., Kubota T., Monden Y., Tsutsumi T., Inoue T., Kawamura N., Tsutsui H., and Sunagawa K. Blockade of NF-kappa B improves cardiac function and survival after myocardial infarction. Am. J. Physiol. -Heart Circul. Physiol. 291 (2006) H1337-H1344
19. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
20. Korsching S. The neurotrophic factor concept: a reexamination. J. Neurosci. 13 (1993) 2739-2748
21. Li W.G., Gavrila D., Liu X.B., Wang L.X., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C.S., and Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation 109 (2004) 2221-2226
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25 (2001) 402-408
23. Lu L., Chen S.S., Zhang J.Q., Ramires F.J., and Sun Y. Activation of nuclear factor-kappa B and its proinflammatory mediator cascade in the infarcted rat heart. Biochem. Biophys. Res. Commun. 321 (2004) 879-885
24. Marx N., Neumann F.J., Ott I., Gawaz M., Koch W., Pinkau T., and Schomig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J. Am. Coll. Cardiol. 30 (1997) 165-170
25. McMillen M.A., Huribal M., Cunningham M.E., Kumar R., and Sumpio B.E. Endothelin-1 increases intracellular calcium in human monocytes and causes production of interleukin-6. Crit. Care Med. 23 (1995) 34-40
26. Murray D.R., and Freeman G.L. Proinflammatory cytokines-predictors of a failing heart?. Circulation 107 (2003) 1460-1462
27. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., and Kangawa K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110 (2004) 3674-3679
28. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., and Kangawa K. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104 (2001) 1430-1435
29. Quehenberger P., Bierhaus A., Fasching P., Muellner C., Klevesath M., Hong M., Stier G., Sattler M., Schleicher E., Speiser W., and Nawroth P.P. Endothelin 1 transcription is controlled by nuclear factor-kappa B in AGE-stimulated cultured endothelial cells. Diabetes 49 (2000) 1561-1570
30. Reichardt L.F. Neuratrophin-regulated signalling pathways. Philos. Trans. R. Soc. B-Biol. Sci. 361 (2006) 1545-1564
31. Sakai S., Miyauchi T., Sakurai T., Kasuya Y., Ihara M., Yamaguchi I., Goto K., and Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 93 (1996) 1214-1222
32. Shimizu Y., Nagaya N., Teranishi Y., Imazu M., Yamamoto H., Shokawa T., Kangawa K., Kohno N., and Yoshizumi M. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem. Biophys. Res. Commun. 310 (2003) 830-835
33. Soeki T., Kishimoto I., Schwenke D.O., Tokudome T., Horio T., Yoshida M., Hosoda H., and Kangawa K. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am. J. Physiol. -Heart Circul. Physiol. 294 (2008) H426-H432
34. Steinberg G.R., Watt M.J., and Febbraio M.A. Cytokine regulation of AMPK signalling. Front. Biosci. 14 (2009) 1902-1916
35. Stewart D.J., Cernacek P., Costello K.B., and Rouleau J.L. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 85 (1992) 510-517
36. Sukhodub A., Jovanovic S., Du Q.Y., Budas G., Clelland A.K., Shen M., Sakamoto K., Tian R., and Jovanovic A. AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K + channels. J. Cell. Physiol. 210 (2007) 224-236
37. Swissa M., Zhou S.M., Chang C.M., Lei A.C., Cates A., Fishbein M.C., Karaguezian H.S., Chen P.S., and Chen L.S. Induction of cardiac nerve sprouting and sympathetic hyperinnervation by subthreshold electrical stimulation of the left stellate ganglion in dogs. J. Am. Coll. Cardiol. 39 (2002) 81A-81A
38. Vaseghi M., and Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog. Cardiovasc. Dis. 50 (2008) 404-419
39. Volterrani M., Manelli F., Cicoira M., Lorusso R., and Giustina A. Role of growth hormone in chronic heart failure-therapeutic implications. Drugs 60 (2000) 711-719
40. Yang L.L., Gros R., Kabir M.G., Sadi A., Gotlieb A.I., Husain M., and Stewart D.J. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109 (2004) 255-261
41. Zhou S., Cao J.M., Tebb Z.D., Ohara T., Huang H.L., Omichi C., Lee M.H., Kenknight B.H., Chen L.S., Fishbein M.C., Karagueuzian H.S., and Chen P.S. Modulation of QT interval by cardiac sympathetic nerve sprouting and the mechanisms of ventricular arrhythmia in a canine model of sudden cardiac death. J. Cardiovasc. Electrophysiol. 12 (2001) 1068-1073
42. Zhou S.M., Cao J.M., Swissa M., Gonzalez-Gomez I., Chang C.M., Chien K., Miyauchi Y., Fu K.J., Yi J., Asotra K., Karagueuzian H.S., Fishbein M.C., Chen P.S., and Chen L.S. Low-affinity nerve growth factor receptor p75NTR immunoreactivity in the myocardium with sympathetic hyperinnervation. J. Cardiovasc. Electrophysiol. 15 (2004) 430-437
43. Zhou S.M., Chen L.S., Miyauchi Y., Miyauchi M., Kar S., Kangavari S., Fishbein M.C., Sharifi B., and Chen P.S. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ. Res. 95 (2004) 76-83